Company Profile
EPAM Systems Stock Price, News & Catalysts
- Ticker:
- EPAM
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
111.26 USD (+0.83%)
Close
Last updated: August 24, 2026
5.39B USD
Market cap
Why the stock is moving
As of Aug 24, 2026, EPAM closed up 0.83% at $111.26. No new same-company headline was identified in the current news window.
Company overview
Business overview
EPAM Systems is a digital engineering and consulting company that supports software development, cloud transformation, and product engineering across industries including life sciences. It is a technology services company rather than a healthcare or biotech operator.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NYSE, EPAM has a global delivery footprint. It sits in digital services and IT consulting rather than biotechnology.
Business Model Characteristics
The company makes money through engineering services, software development, and consulting engagements. Investors focus on client spending, project demand, margins, and the health of enterprise technology budgets.
Position Within the Biotechnology Landscape
EPAM is outside biotech, though it can participate indirectly through life sciences digital transformation work. It belongs to the IT services layer, not the drug-development or medtech stack.
Future catalysts
- EPAM’s catalysts are digital-transformation demand, AI project wins, and regulated-industry spending from life sciences and healthcare clients. The important part is whether the update changes the odds of the next milestone rather than just confirming the current story. If the event is positive, it can improve the market’s willingness to pay for the name ahead of the following catalyst.
Recent news
- 01
- 02
- 03
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of EPAM Systems (EPAM)?
EPAM Systems (EPAM) most recently closed at 111.26 USD, a +0.83% move versus the previous session.
What is the market cap of EPAM Systems (EPAM)?
EPAM Systems currently has a market capitalization of 5.39B USD on BioPharmSignal.
What does EPAM Systems do?
EPAM Systems is a digital engineering and consulting company that supports software development, cloud transformation, and product engineering across industries including life sciences. It is a technology services company rather than a healthcare or biotech operator.
On which exchange is EPAM stock listed?
EPAM Systems (EPAM) is associated with NASDAQ, United States, Biopharma.
What is Systems?
EPAM Systems is a digital engineering and consulting company that supports software development, cloud transformation, and product engineering across industries including life sciences.
Which conditions is EPAM Systems targeting with Systems?
EPAM Systems is a digital engineering and consulting company that supports software development, cloud transformation, and product engineering across industries including life sciences. It is a technology services company rather than a healthcare or biotech operator. EPAM’s catalysts are digital-transformation demand, AI project wins, and regulated-industry...
How does EPAM Systems describe recent progress with Systems?
EPAM’s catalysts are digital-transformation demand, AI project wins, and regulated-industry spending from life sciences and healthcare clients. The important part is whether the update changes the odds of the next milestone rather than just confirming the current story. If the event is positive, it can improve the market’s willingness to pay for the name...
What future catalysts are investors watching for EPAM Systems?
EPAM’s catalysts are digital-transformation demand, AI project wins, and regulated-industry spending from life sciences and healthcare clients. The important part is whether the update changes the odds of the next milestone rather than just confirming the current story. If the event is positive, it can improve the market’s willingness to pay for the name...
